Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
AUR-101 by Aurigene Oncology for Psoriatic Arthritis: Likelihood of Approval
AUR-101 is under clinical development by Aurigene Oncology and currently in Phase II for Psoriatic Arthritis. According to GlobalData, Phase...
Data Insights
AUR-101 by Aurigene Oncology for Ankylosing Spondylitis (Bekhterev's Disease): Likelihood of Approval
AUR-101 is under clinical development by Aurigene Oncology and currently in Phase II for Ankylosing Spondylitis (Bekhterev's Disease). According to...